274 related articles for article (PubMed ID: 28498717)
1. Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration.
Ramos E; Egea J; de Los Ríos C; Marco-Contelles J; Romero A
Future Med Chem; 2017 May; 9(8):765-780. PubMed ID: 28498717
[TBL] [Abstract][Full Text] [Related]
2. Melatonin as a structural template in the development of novel drugs for neurodegenerative disorders.
Korábečný J
Ceska Slov Farm; 2018; 67(2):51-58. PubMed ID: 30189733
[TBL] [Abstract][Full Text] [Related]
3. New melatonin-cinnamate hybrids as multi-target drugs for neurodegenerative diseases: Nrf2-induction, antioxidant effect and neuroprotection.
Buendia I; Navarro E; Michalska P; Gameiro I; Egea J; Abril S; López A; González-Lafuente L; López MG; León R
Future Med Chem; 2015; 7(15):1961-9. PubMed ID: 26496465
[TBL] [Abstract][Full Text] [Related]
4. Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties.
Fernández-Bachiller MI; Pérez C; Campillo NE; Páez JA; González-Muñoz GC; Usán P; García-Palomero E; López MG; Villarroya M; García AG; Martínez A; Rodríguez-Franco MI
ChemMedChem; 2009 May; 4(5):828-41. PubMed ID: 19308922
[TBL] [Abstract][Full Text] [Related]
5. New melatonin-N,N-dibenzyl(N-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.
López-Iglesias B; Pérez C; Morales-García JA; Alonso-Gil S; Pérez-Castillo A; Romero A; López MG; Villarroya M; Conde S; Rodríguez-Franco MI
J Med Chem; 2014 May; 57(9):3773-85. PubMed ID: 24738476
[TBL] [Abstract][Full Text] [Related]
6. Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer's Disease.
Spilovska K; Korabecny J; Nepovimova E; Dolezal R; Mezeiova E; Soukup O; Kuca K
Curr Top Med Chem; 2017; 17(9):1006-1026. PubMed ID: 27697055
[TBL] [Abstract][Full Text] [Related]
7. Melatonin oxidative stress and neurodegenerative diseases.
Srinivasan V
Indian J Exp Biol; 2002 Jun; 40(6):668-79. PubMed ID: 12587715
[TBL] [Abstract][Full Text] [Related]
8. New cinnamic - N-benzylpiperidine and cinnamic - N,N-dibenzyl(N-methyl)amine hybrids as Alzheimer-directed multitarget drugs with antioxidant, cholinergic, neuroprotective and neurogenic properties.
Estrada M; Herrera-Arozamena C; Pérez C; Viña D; Romero A; Morales-García JA; Pérez-Castillo A; Rodríguez-Franco MI
Eur J Med Chem; 2016 Oct; 121():376-386. PubMed ID: 27267007
[TBL] [Abstract][Full Text] [Related]
9. Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer's Disease: An Update.
de Freitas Silva M; Dias KST; Gontijo VS; Ortiz CJC; Viegas C
Curr Med Chem; 2018; 25(29):3491-3525. PubMed ID: 29332563
[TBL] [Abstract][Full Text] [Related]
10. Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease.
Jeřábek J; Uliassi E; Guidotti L; Korábečný J; Soukup O; Sepsova V; Hrabinova M; Kuča K; Bartolini M; Peña-Altamira LE; Petralla S; Monti B; Roberti M; Bolognesi ML
Eur J Med Chem; 2017 Feb; 127():250-262. PubMed ID: 28064079
[TBL] [Abstract][Full Text] [Related]
11. The antiapoptotic activity of melatonin in neurodegenerative diseases.
Wang X
CNS Neurosci Ther; 2009; 15(4):345-57. PubMed ID: 19818070
[TBL] [Abstract][Full Text] [Related]
12. The Vital Role of Melatonin and Its Metabolites in the Neuroprotection and Retardation of Brain Aging.
Bocheva G; Bakalov D; Iliev P; Tafradjiiska-Hadjiolova R
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791160
[TBL] [Abstract][Full Text] [Related]
13. Melatonin and Melatonergic Influence on Neuronal Transcription Factors: Implications for the Development of Novel Therapies for Neurodegenerative Disorders.
Onaolapo OJ; Onaolapo AY; Olowe OA; Udoh MO; Udoh DO; Nathaniel TI
Curr Neuropharmacol; 2020; 18(7):563-577. PubMed ID: 31885352
[TBL] [Abstract][Full Text] [Related]
14. Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders.
Giri A; Mehan S; Khan Z; Das Gupta G; Narula AS; Kalfin R
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3867-3895. PubMed ID: 38225412
[TBL] [Abstract][Full Text] [Related]
15. [Effects of melatonin in the brain of the senescence-accelerated mice-prone 8 (SAMP8) model].
Gutierrez-Cuesta J; Tajes M; Jimenez A; Camins A; Pallas M
Rev Neurol; 2011 May; 52(10):618-22. PubMed ID: 21488009
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core.
Lin H; Li Q; Gu K; Zhu J; Jiang X; Chen Y; Sun H
Curr Top Med Chem; 2017; 17(27):3000-3016. PubMed ID: 28714419
[TBL] [Abstract][Full Text] [Related]
17. (-)-Meptazinol-melatonin hybrids as novel dual inhibitors of cholinesterases and amyloid-β aggregation with high antioxidant potency for Alzheimer's therapy.
Cheng S; Zheng W; Gong P; Zhou Q; Xie Q; Yu L; Zhang P; Chen L; Li J; Chen J; Chen H; Chen H
Bioorg Med Chem; 2015 Jul; 23(13):3110-8. PubMed ID: 26025073
[TBL] [Abstract][Full Text] [Related]
18. Melatonin and the aging brain.
Bondy SC; Sharman EH
Neurochem Int; 2007 Mar; 50(4):571-80. PubMed ID: 17276551
[TBL] [Abstract][Full Text] [Related]
19. Melatonin as a promising modulator of aging related neurodegenerative disorders: Role of microRNAs.
Alamdari AF; Rahnemayan S; Rajabi H; Vahed N; Kashani HRK; Rezabakhsh A; Sanaie S
Pharmacol Res; 2021 Nov; 173():105839. PubMed ID: 34418564
[TBL] [Abstract][Full Text] [Related]
20. Multitarget-directed ligands for neurodegenerative diseases: real opportunity or blurry mirage?
Benchekroun M; Maramai S
Future Med Chem; 2019 Feb; 11(4):261-263. PubMed ID: 30763133
[No Abstract] [Full Text] [Related]
[Next] [New Search]
